An upgraded global response to future potential pandemic threats would give the best chance of eliminating new infectious diseases at source before they spread globally.
Academic rigour, journalistic flair
Articles on Pandemic
Displaying 161 - 180 of 1573 articles
However, there are still challenges for fathers taking on equal or primary care responsibilities.
The XBB.1.5 subvariant — nicknamed ‘Kraken’ — is arguably the most genetically rich and most transmissible SARS-CoV-2 Omicron subvariant yet.
Suspended MP Andrew Bridgen’s comments are a prime example.
XBB.1.5, or ‘kraken’, can evade our immune systems better than earlier variants, and appears to be more infectious. But it’s not cause for alarm.
Data suggests the bivalent boosters are working well against omicron.
Companies around the world are rapidly reshoring factories, investing in new technologies and building their inventories – shifts that all mean higher costs for consumers.
Deep-seated structural issues in the NHS affect all patients, however they particularly impact people with long COVID who are trying to both understand a complex new illness and access healthcare.
China pursued COVID zero for too long and is now paying the price. But the rest of the world doesn’t have too much to worry about.
After a year of omicron variants, will we ever see a new variant of concern?
A new study has looked at more than 15,000 people across 21 countries to assess whether vaccinated and unvaccinated people discriminate against each other.
Workers have filed the most union petitions since 2015 and the number of strikes have surged, but whether this turns into a sustained increase in membership rates is still unclear.
If you’ve had trouble sleeping during or after a COVID infection, you’re not alone.
Privatization is an idea that — like a zombie —just won’t die. It’s re-emerging with calls to solve the long-term care crisis with for-profit care homes. Evidence refutes the same old arguments.
The microbes in our gut have many roles, including to support immune function.
One thing is for certain though – the pandemic is not over yet.
‘Tis the season… for coughs, colds and COVID, it seems. So what should you do if you find yourself with symptoms on Christmas Day?
Hancock isn’t the first politician to attempt redemption through memoir.
In particular, a drug called Evusheld could offer protection for people who are vulnerable – but the UK isn’t offering it.
The long-term care sector is currently being held together by a very vulnerable workforce, and is at risk of failing without immediate solutions.
Top contributors
-
Associate Professor, Epidemiology, Deakin University
-
Professor of Medicine, University of Virginia
-
Lecturer in Psychology, Swansea University
-
Joel Lexchin is a Friend of The Conversation.
Professor Emeritus of Health Policy and Management, York University, Canada
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
-
Professor, Biology, York University, Canada
-
Associate Professor of Viral Immunology, Department of Pathobiology, University of Guelph
-
Dean and Professor of Public Health, The Ohio State University
-
Professor of Epidemiology Healthcare Infection and Infectious Diseases Control, UNSW Sydney
-
Research associate, Warren Alpert Medical School, Brown University, Brown University
-
Professor and Chair, Department of Journalism, Stellenbosch University
-
Professor of Operations Management & Business Analytics, Carey Business School, Johns Hopkins University
-
Professor of Medicine, University of East Anglia
-
Professor of Immunology and Associate Dean, Research and Graduate Studies, University of Guelph
-
Professor of Public Health, University of Otago
